Drugging PI3K in cancer: refining targets and therapeutic strategies

The phosphatidylinositol-3 kinase (PI3K) pathway is one of the most frequently activated pathogenic signalling routes in human cancers, making it a rational and important target for innovative anticancer drug development and precision medicine. The three main classes of PI3K inhibitors currently in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yap, Timothy A, Bjerke, Lynn, Clarke, Paul A, Workman, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728196/
https://www.ncbi.nlm.nih.gov/pubmed/26117819
http://dx.doi.org/10.1016/j.coph.2015.05.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728196/
https://www.ncbi.nlm.nih.gov/pubmed/26117819
http://dx.doi.org/10.1016/j.coph.2015.05.016

Ejemplares similares